0001415889-24-004121.txt : 20240216
0001415889-24-004121.hdr.sgml : 20240216
20240216162015
ACCESSION NUMBER: 0001415889-24-004121
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240215
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SOUTHWELL DAVID P
CENTRAL INDEX KEY: 0001251553
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 24648651
MAIL ADDRESS:
STREET 1: C/O INOTEK PHARMACEUTICALS CORPORATION
STREET 2: 91 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
form4-02162024_040201.xml
X0508
4
2024-02-15
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001251553
SOUTHWELL DAVID P
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
true
false
false
false
0
Common Stock
2024-02-15
4
A
0
4000
0
A
14500
D
Stock Option (Right to Buy)
25.69
2024-02-15
4
A
0
10000
0
A
2034-02-14
Common Stock
10000
10000
D
Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death.
This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024.
/s/ Avraham S. Adler, Attorney-in-Fact
2024-02-16